# Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease

> **NCT07384897** · NA · RECRUITING · sponsor: **Université Catholique de Louvain** · enrollment: 425 (estimated)

## Conditions studied

- Lung Cancer (Diagnosis)
- Sarcoidosis
- Chronic Obstructive Pulmonary Disease
- Immunotherapy Resistance
- Immune Dysregulation

## Interventions

- **OTHER:** Peripheral Blood Collection for Immune Profiling

## Key facts

- **NCT ID:** NCT07384897
- **Lead sponsor:** Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-17
- **Primary completion:** 2030-12-01
- **Final completion:** 2032-02-17
- **Target enrollment:** 425 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07384897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07384897, "Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07384897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*